What is acute ischemic stroke?

Acute ischemic stroke is a medical condition caused by a sudden blockage of blood flow to the brain, leading to brain tissue damage.

How big is the Acute Ischemic Stroke Therapeutics Market?

The global Acute Ischemic Stroke Therapeutics Market size was estimated at USD 8.9 billion in 2022 and is expected to reach USD 14.1 billion in 2032.

What is the Acute Ischemic Stroke Therapeutics Market growth?

The global Acute Ischemic Stroke Therapeutics Market is expected to grow at a compound annual growth rate of 5.1%. From 2023 To 2032

Who are the key companies/players in the Acute Ischemic Stroke Therapeutics Market?

Some of the key players in the Acute Ischemic Stroke Therapeutics Markets are Boehringer Ingelheim GmbH, Hoffmann-La Roche, Bristol-Myers Squibb, Pfizer, AstraZeneca, Johnson & Johnson, Sanofi, Daiichi Sankyo, Athersys, Other Key Players

What is the Acute Ischemic Stroke Therapeutics Market?

The Acute Ischemic Stroke Therapeutics Market refers to the industry that develops and sells treatments and medications for patients suffering from acute ischemic strokes.

What are the common treatments for acute ischemic stroke?

Common treatments include thrombolytic therapy (clot-busting drugs), mechanical thrombectomy (clot removal procedures), and supportive care to manage symptoms.

Acute Ischemic Stroke Therapeutics Market

Acute Ischemic Stroke Therapeutics Market by Drug Class (Thrombolytics, Antiplatelets, Anticoagulants, Statins, Antihypertensives), by Route of Administration (Oral, Parenteral), by Distribution Channel, Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Published date:
July 2023
Report ID:
53968
Number of Pages:
242
Format:

Quick Contact

Our Clients